Navigation Links
Skin-disease patients show brain immunity to faces of disgust
Date:8/27/2009

People with psoriasis an often distressing dermatological condition that causes lesions and red scaly patches on the skin are less likely to react to looks of disgust by others than people without the condition, new research has found.

University of Manchester scientists used magnetic resonance imaging (MRI) scans to compare the brains of 26 men, half of whom had chronic psoriasis. The researchers looked at the insular cortex a part of the brain triggered by both feelings and observations of disgust to see how participants responded to images of disgusted faces.

The study, published in the Journal of Investigative Dermatology, found that the volunteers with psoriasis had a much weaker response in their insular cortex than the healthy volunteers, suggesting they have developed a coping mechanism to protect themselves from adverse emotional responses to their condition by others.

"Psoriasis has a significant negative impact on the physical and psychological well-being of those affected but little is known about the neurocognitive mechanisms of how patients cope with the adverse social stigma associated with visible skin lesions," said Dr Elise Kleyn, the dermatologist who carried out the research.

"We had previously shown that psoriasis patients commonly believe that they will be evaluated solely on the basis of their skin and so often avoid social situations they think will be stressful or humiliating as a coping mechanism.

"For this study we wanted to investigate whether the social impact of psoriasis is associated with altered cognitive processing in response to facial expressions of disgust by measuring brain activity in the insular cortex.

"We found a significantly reduced response in the insular cortex in the patients compared with the control volunteers when observing disgusted faces, but also that patients were half as likely to recognise that a face was expressing disgust. This was not the case for other facial expressions, such as fear."

The research team, which was headed by world-renowned dermatologist Professor Chris Griffiths, believe that one explanation for their findings is that psoriasis patients develop a coping mechanism to protect them from stressful emotional responses by blocking the processing of disgusted facial expressions encountered in others.

Dr Kleyn added: "We believe that other stigmatising conditions, such as severe acne or scarring, may elicit similar findings, although further research is clearly needed. We think the insights provided by this study, however, could generate new strategies for managing stigmatising skin diseases."


'/>"/>

Contact: Aeron Haworth
aeron.haworth@manchester.ac.uk
44-161-275-8383
University of Manchester
Source:Eurekalert

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
6. Restricting Blood Flow May Help Heart Bypass Patients
7. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
8. Study provides hope that some transplant patients could live free of antirejection drugs
9. Study provides hope that some transplant patients could live free of anti-rejection drugs
10. Longer ambulance journeys boost death risk for seriously ill patients
11. Expenses Overshadow Optimism for Kidney Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... FALLS CHURCH, Va. (PRWEB) , ... February 23, 2017 , ... ... , worries, or problems. He has also continued to spiritually evolve, which is the ... his published book “ Our Spiritual Truths ” (published by Balboa Press) attempts to ...
(Date:2/22/2017)... Los Angeles, CA (PRWEB) , ... February 22, 2017 , ... ... medical detox treatment to the thousands of individuals who have recently fallen victim to ... accredited hospital in Orange County, California, where they are free from the shame, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... accurately understand each Medicare Advantage member’s risk, identify any gaps-in-coding, as well ... solution helps transform the HCC Risk Adjustment process from a typical fragmented ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This premier ... absorption from the mouth into the bloodstream. Far outpacing the absorption ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine Review, ... is featuring Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to Know.” ... of neurosurgeons in Michigan performing minimally invasive back surgery that often results in ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... York , February 23, 2017 ... Holter Monitor Market are GE Healthcare, Koninklijke Philips N.V., ... about 48% in the global market in 2015. Strong ... two key factors assessed to be aiding these players ... Research states that the players in the global market ...
(Date:2/23/2017)... Mass. , Feb. 23, 2017   ... partner to global in vitro diagnostics manufacturers and ... series titled "Catalyzing Implementation of NGS-Based Tests" to ... March 30, 2017 at 11am Eastern Standard Time ... is to highlight the need for improved performance ...
(Date:2/23/2017)... , Feb. 23, 2017 MabVax ... oncology drug development company, announces that it has ... Administration (FDA) authorizing the initiation a Phase I ... for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is ... MabVax plans to initiate the phase I clinical ...
Breaking Medicine Technology: